ME Therapeutics Holdings Inc. (CNSX: METX)
Health Care · Biotechnology · CA
CA$1.80
-35.71% today · -69.7% 1Y
ME Therapeutics Holdings Inc. (CNSX: METX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $38.53M.
Over the last twelve months the share price has lost 69.7%, trading between 0.79 and 8.00.
Tweenvest scores ME Therapeutics Holdings Inc. across four factors: quality 44/100, value 19/100. Its strongest factor is quality.
METX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $38.53M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.05
- Dividend yield
- —
- Beta (5Y)
- -0.01
- 52-week high
- CA$8.00
- 52-week low
- CA$0.79
- Avg volume (3M)
- —
- Shares outstanding
- 30.39M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| INmune Bio Inc.NasdaqCM: INMB | $40.52M | $1.46 | -4.58% |
| TegoScience Inc.KOSDAQ: A191420 | $40.24M | ₩6,700.00 | -5.63% |
| Instil Bio, Inc.NasdaqCM: TIL | $40.08M | $5.91 | -12.31% |
| Genomics BioSci & Tech. Co.,Ltd.TWSE: 4195 | $38.71M | NT$15.70 | -3.68% |
| TMS Co., Ltd.TSE: 4891 | $38.44M | ¥132.00 | +0.76% |
| J2KBIO Co., Ltd.KOSDAQ: A420570 | $38.16M | ₩8,700.00 | -8.52% |
| eXoZymes, Inc.NasdaqCM: EXOZ | $37.96M | $4.09 | -22.10% |
| BrightPath Biotherapeutics Co., Ltd.TSE: 4594 | $37.83M | ¥43.00 | -4.44% |
Figures last refreshed Oct 18, 2026.